Jiemiao Hu

The University of Texas MD Anderson Cancer Center

Also affiliated with Xidian University, Wuhan University, Renmin Hospital of Wuhan University, Hangzhou DAC Biotech (China)

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 13 papers. Top paper: “Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients”.

Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

Science(2018)10.1126/science.aan4236

N/A

1.3DataRank · unranked

4585 citations

C. N. Spencer, Luigi Nezi, Alexandre Reuben, Miles C. Andrews, Tatiana V. Karpinets +89 more

Lysine acetylation of NKG2D ligand Rae-1 stabilizes the protein and sensitizes tumor cells to NKG2D immune surveillance

Cancer Letters(2020)10.1016/j.canlet.2020.12.002

N/A

0DataRank · unranked

9 citations

Xueqing Xia, Qingnan Zhao, Shulin Li, Jiemiao Hu

Regulation of tumor immune suppression and cancer cell survival by CXCL1/2 elevation in glioblastoma multiforme

Science Advances(2021)10.1126/sciadv.abc2511

N/A

0DataRank · unranked

145 citations

Qingnan Zhao, Ling-Yuan Kong, Jian Wang, Jun Yan, Xueqing Xia +4 more

WSX1 act as a tumor suppressor in hepatocellular carcinoma by downregulating neoplastic PD-L1 expression

Nature Communications(2021)10.1038/s41467-021-23864-9

N/A

0DataRank · unranked

57 citations

Xueqing Xia, Jiemiao Hu, Natalie W. Fowlkes, Shulin Li, Man Wu

Cell membrane-anchored and tumor-targeted IL-12 (attIL12)-T cell therapy for eliminating large and heterogeneous solid tumors

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-003633

N/A

0DataRank · unranked

55 citations

Qing Yang, Wendong Zhang, Hongwei Du, Yu‐Hui Chen, Qingnan Zhao +10 more

Membrane-Anchored and Tumor-Targeted IL12 (attIL12)-PBMC Therapy for Osteosarcoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-0721

N/A

0DataRank · unranked

16 citations

Jiemiao Hu, Zhiliang Jia, Qi Wang, Jing Wang, Long Hoang Dao +6 more

Membrane-anchored and tumor-targeted Il-12(attIL12) PBMC therapy for osteosarcoma

Research Square(2022)10.21203/rs.3.rs-1392663/v1

N/A

0DataRank · unranked

1 citations

Jiemiao Hu, Zhiliang Jia, Qi Wang, Jing Wang, LongHoang Dao +5 more

FGL2-targeted T cells induced tumor-specific brain resident TRM cells preventing glioblastoma recurrence

Research Square(2022)10.21203/rs.3.rs-1632572/v1

N/A

0DataRank · unranked

0 citations

Ling‐Yuan Kong, Shan Jiang, Xiangjun Tian, Jing Wang, Rintaro Hashizume +12 more

FGL2-targeting T cells exhibit antitumor effects on glioblastoma and recruit tumor-specific brain-resident memory T cells

Nature Communications(2023)10.1038/s41467-023-36430-2

N/A

0DataRank · unranked

32 citations

Jiemiao Hu, Ling‐Yuan Kong, Shan Jiang, Xiangjun Tian, Jing Wang +11 more

Data from Membrane-Anchored and Tumor-Targeted IL12 (attIL12)-PBMC Therapy for Osteosarcoma

(2023)10.1158/1078-0432.c.6532343.v1

N/A

0DataRank · unranked

0 citations

Jiemiao Hu, Zhiliang Jia, Qi Wang, Jing Wang, Long Dao +6 more

Data from Membrane-Anchored and Tumor-Targeted IL12 (attIL12)-PBMC Therapy for Osteosarcoma

(2023)10.1158/1078-0432.c.6532343

N/A

0DataRank · unranked

0 citations

Jiemiao Hu, Zhiliang Jia, Qi Wang, Jing Wang, Long Dao +6 more

Cell membrane-anchored and tumor-targeted IL-12 T-cell therapy destroys cancer-associated fibroblasts and disrupts extracellular matrix in heterogenous osteosarcoma xenograft models

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-006991

N/A

0DataRank · unranked

36 citations

Alexander J. Lazar, Davis R. Ingram, Wei‐Lien Wang, Wendong Zhang, Zhiliang Jia +7 more

Collagen-disrupting attIL12 TIL therapy boosts deep T cell infiltration via dual signaling activation and CCKAR reduction in sarcomas

Proceedings of the National Academy of Sciences(2025)10.1073/pnas.2507542122

N/A

0DataRank · unranked

1 citations

Harjeet Singh, Yining Jin, W. Zhang, Jian Wang, Xueqing Xia +4 more